Gilead Sciences Buys CymaBay Therapeutics for $4.3B, Boosting Liver Disease Treatment Options
Gilead Sciences is acquiring CymaBay Therapeutics for $4.3 billion, enhancing its liver disease portfolio with seladelpar, a drug for primary biliary cholangitis.
San Jose Police Score Major Drug Bust: Seizes Cash, Cocaine, and Firearm from Convicted Felon
San Jose Police conducted a routine traffic stop, uncovering half a pound of crack cocaine. A subsequent house search led to the seizure of a loaded gun and $38,000. The convicted felon driver was arrested.
East Palo Alto Police Issue Urgent Appeal for Witnesses Following University Ave. Stabbing
East Palo Alto Police seek a mustached suspect in a dark hooded sweatshirt after a stabbing incident left one man critically injured and another with minor wounds on February 8 near University Ave. and Bell St.
San Jose Man Indicted in Federal Court for Alleged Role in Bay Area Bicycle Theft Syndicate
Victoriano Romero faces federal charges for allegedly running a bike theft operation in the Bay Area, exporting stolen bikes to Mexico for resale. He was indicted and released on bond, with his court date set for April 10, 2024.












